{
    "2019-06-14": [
        [
            {
                "time": "",
                "original_text": "八部门联合印发遏制结核病计划 2022年发病率需降至55/10万以下",
                "features": {
                    "keywords": [
                        "八部门",
                        "联合印发",
                        "遏制",
                        "结核病计划",
                        "2022年",
                        "发病率",
                        "55/10万"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "渝股看台｜智飞生物拟现金分红8亿元，华森制药引入美国抗焦虑药物",
                "features": {
                    "keywords": [
                        "渝股",
                        "智飞生物",
                        "现金分红",
                        "8亿元",
                        "华森制药",
                        "美国",
                        "抗焦虑药物"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}